Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. (Blood, 1998)

(untitled) - Hale, G; Zhang, M; Bunjes, D; Prentice, H; Spence, D; Horowitz, M; Barrett, A; Waldmann, H